RAD301

· Radiopharm Theranostics, Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RAD301, covering 2026-03-30 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors [Phase 1]